Literature DB >> 1419791

Efficacy of high-dose intravenous gammaglobulin in the management of acquired von Willebrand's disease during orthopaedic surgery.

S Gross1, C Traulle, J C Capiod, B Roussel, B Lafon, E Hayek, J Dieval, J Delobel.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1419791     DOI： 10.1111/j.1365-2141.1992.tb04610.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

Review 1.  Intravenous immunoglobulin therapy for acquired coagulation inhibitors: a critical review.

Authors:  Koji Yamamoto; Junki Takamatsu; Hidehiko Saito
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

Review 2.  Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.

Authors:  Hiroshi Mohri
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

Review 3.  High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease.

Authors:  P J Van Genderen; D N Papatsonis; J J Michiels; J J Wielenga; J Stibbe; F J Huikeshoven
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.